Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hian Li Esther Chan"'
Autor:
Esther K Y Ng, Hoi Yin Loi, Sanjay de Mel, Xin Liu, Wan Lu Pang, Tiffany Tang, Xi Yun Zhang, Joanne Lee, Edward Kh Chow, Liang Piu Koh, Siok Bian Ng, Jasmine Goh, Soon Thye Lim, Choon Kiat Ong, Hian Li Esther Chan, Daryl Tan, Masturah Bte Mohd Abdul Rashid, Yen-Lin Chee, Nur Atiqa Diana Binte Rahmat, Michelle Poon, Wee Joo Chng, Nagavalli Somasundaram, Daryl Ming Zhe Cheah, Xueying Goh, Teck Guan Soh, Lip Kun Tan, Jason Yongsheng Chan, Michal Marek Hoppe, Dachuan Huang, Patrick Jaynes, Anand D. Jeyasekharan, Yi Ching Yuen
Publikováno v:
Blood. 138:720-720
Introduction While combination therapy is the standard of care for relapsed/ refractory non-Hodgkin lymphoma (RR-NHL), the choice of combinations for an individual patient is empirical, and response rates remain poor. Here we explore the use of a hyb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84676d3004399121037a2105bbfa72a2
https://doi.org/10.1182/blood-2021-149331
https://doi.org/10.1182/blood-2021-149331
Autor:
Sanjay de Mel, Wee Lee William Chan, Yen Lin Chee, Joanne Lee, Ian Wee, Anand D. Jeyasekharan, Miny Samuel, Hian Li Esther Chan, Vanessa Cl Chong, Wee Joo Chng, Michelle Poon
Publikováno v:
Blood. 138:1358-1358
Background Waldenstrom macroglobulinemia (WM) is a rare haematological malignancy characterised by infiltration of the bone marrow by clonal lymphoplasmocytic cells and serum monoclonal IgM gammopathy. Rituximab based chemo-immunotherapy has long bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33c50115408e2ac5bfa360bfbbf2ea9a
https://doi.org/10.1182/blood-2021-150678
https://doi.org/10.1182/blood-2021-150678
Autor:
Lay Poh Khoo, Soon Thye Lim, Anand D. Jeyasekharan, Hian Li Esther Chan, Yen Lin Chee, Joanne Lee, Michelle Poon, Nagavalli Somasundaram, Yong Sheng Jason Chan, Sanjay de Mel
Publikováno v:
Blood. 138:1371-1371
Introduction There is currently no standard of care for the upfront management of patients with mature T cell non-Hodgkin lymphomas (T-NHL). The role of anthracyclines in the treatment of T-NHL remains unclear and is also associated with significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2ef1522e800fd69da85893996d8436a
https://doi.org/10.1182/blood-2021-152633
https://doi.org/10.1182/blood-2021-152633
Publikováno v:
Annals of Diagnostic Pathology. 24:40-46
Primary cardiac lymphoma (PCL) is a rare extranodal lymphoma that involves only the heart and/or pericardium. Primary cardiac lymphoma is much less common in immunocompetent patients compared with those who are immunosuppressed. Patients with PCL hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da9d63de7ddeae5e4b7a55d9f245a84e
https://doi.org/10.1016/j.anndiagpath.2016.05.005
https://doi.org/10.1016/j.anndiagpath.2016.05.005
Autor:
Cinnie Yentia Soekojo, Hian Li Esther Chan, Louis-Pierre Girard, Joanne Shu Xian Lee, Anand D. Jeyasekharan, Liang Piu Koh, Michelle Poon, Yin Jie Koh, Yen-Lin Chee, Xin Liu, Miny Samuel, Sanjay de Mel
Publikováno v:
Blood. 136:17-17
Introduction: There is currently no consensus on the optimal frontline therapy for patients with T cell Non-Hodgkin lymphomas (T-NHL). Consolidative autologous stem cell transplant (ASCT) is frequently offered to the patients with chemosensitive dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56e46f01d153c66206157fa58da13a08
https://doi.org/10.1182/blood-2020-138700
https://doi.org/10.1182/blood-2020-138700
Autor:
Xiao-Shi Saw, Lon-Wann Sai, Hian Li Esther Chan, Xiaojuan Chen, Yee Mei Lee, Michelle Poon, Yen Lin Chee, Chin-Hin Ng, Shi Hui Clarice Choong, Melissa G. Ooi, Foong-Gwan Lee
Publikováno v:
Blood. 134:2152-2152
Background: High dose cytarabine (HiDAC) consolidation in AML is conventionally given in the inpatient setting over approximately 6-7 days. Patients usually tolerate this treatment uneventfully, with occasional cytarabine-related fever or rash. As th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::734c90dad36969d8399e81278f253b7f
https://doi.org/10.1182/blood-2019-129858
https://doi.org/10.1182/blood-2019-129858
Autor:
Suk Teng Chin, Sanjay de Mel, Eng Soo Yap, Anand D. Jeyasekharan, Joanne Shu Xian Lee, Yee Mei Lee, Hian Li Esther Chan, Vanessa Cl Chong, Liu Xin, Liang Piu Koh, Yen-Lin Chee, Michelle Poon, Yi Ching Yuen
Publikováno v:
Blood. 132:4222-4222
BACKGROUND/OBJECTIVE: DLBCL is a heterogeneous disease which on gene expression profiling studies (GEP) can be divided into 2 distinct subtypes, germinal center (GCB) as well as activated B cell subtype (non GCB) based on the cell-of-origin. Immunoch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02427407c332e80b9b9b3cfc97b20e4a
https://doi.org/10.1182/blood-2018-99-119672
https://doi.org/10.1182/blood-2018-99-119672
Autor:
Wee Joo Chng, Soo-Chin Lee, Caroline Hui Ting Aw, Suk Teng Chin, Joanne Shu Xian Lee, Yen-Lin Chee, Yi Ching Yuen, Li Mei Poon, Nagavalli Somasundaram, Chia Meng Teoh, Benedict Yan, Tiffany Tang, Xin Liu, Chiea Chuen Khor, Noorul Farzana, Hian Li Esther Chan, Joanne Ngeow, E. Shyong Tai, Boon Cher Goh, Choon Kiat Ong, Folefac Aminkeng
Publikováno v:
Blood. 132:4111-4111
Background Hodgkin lymphoma (HL) accounts for 15% of all cancer diagnosis in young adults. Standard of care is ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine), which has resulted in overall cures of 70-90%. In the setting of HL, bleomycin is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98f491f2bd1e8b644afb4a2ac6915344
https://doi.org/10.1182/blood-2018-99-113952
https://doi.org/10.1182/blood-2018-99-113952
Autor:
Yuh Shan Lee, Nicholas Francis Grigoropoulos, Soon Thye Lim, Suk Teng Chin, Hian Li Esther Chan, Michelle Poon, Yeow Tee Goh, Joanne Shu Xian Lee, Tiffany Tang, Yen-Lin Chee, Vanessa Cl Chong, Colin Phipps Diong, Anand D. Jeyasekharan, Liang Piu Koh, Xin Liu, Richard Quek, Chandramouli Nagarajan, Daryl Tan, Miriam Tao, Mohamad Farid, Sanjay de Mel
Publikováno v:
Blood. 132:2885-2885
Background/Objective: Marginal zone B-cell lymphomas (MZL) represent a heterogeneous group of indolent lymphomas, comprising of MALT lymphomas, nodal MZL and splenic MZL. Currently, there has been no widely accepted prognostic indices for these lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf9551899fef1ad26d83f02156a5d4ac
https://doi.org/10.1182/blood-2018-99-118364
https://doi.org/10.1182/blood-2018-99-118364
Publikováno v:
Blood. 118:5060-5060
Abstract 5060 Introduction In multiple myeloma, cytogenetics is informative in only about a third of patients. Despite this limitation, it remains a commonly available laboratory investigation that has prognostic utility and allows detection of globa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4ffb8968940e7d514d141f9b690c8a2
https://doi.org/10.1182/blood.v118.21.5060.5060
https://doi.org/10.1182/blood.v118.21.5060.5060